CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled
Drug / intervention
Treatment with IPL devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03945383
NCT03945383N/ACompleted

Clinical Investigation of Safety and Efficacy of the Emerald IPL Device for Hair Reduction for the Extension of Its Intended Use to Face and to Skin Type V Population

Philips Healthcare·interventional·Posted May 10, 2019·Updated Oct 19, 2022

In Brief

A clinical study evaluating Treatment with IPL device for Hair Removal. Completed, enrolled 120 participants across 3 sites.

Detailed Summary

Prospective, multi-center, single-arm, single blinded (Philips hair counter) study in healthy women of skin types I up to and including V. Safety and efficacy of hair removal with the Emerald IPL-device will be investigated for treatment in face of subjects with ST I - IV and for treatment in face, axilla, bikini area, and legs of subjects with ST V. In-clinic, the study subjects will undergo twelve IPL-treatments bilaterally at the qualified areas (face and / or axilla, bikini line, and legs) with the Emerald IPL device applied by a device operator. Hair re-growth in each area will be evaluated separately and across all skin types. After the 4 bi-weekly treatments, one follow-up visit will be organized two weeks after the 4th treatment. After the completion of the full treatment cycle (12 treatments), subjects will be followed for 1 and 3 months (short-term follow-up) and for 6, 9 and 12 months (long-term follow up).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHair Removal
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMay 10, 2019
Enrollment StartApr 15, 2019
Primary CompletionJan 14, 2022
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 7.1 years ago

Interventions

Treatment with IPL devicedevice

Treatment with IPL device